BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burnett E, Parashar UD, Tate JE. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis. Lancet Glob Health 2020;8:e1195-202. [PMID: 32827481 DOI: 10.1016/S2214-109X(20)30262-X] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang L, Shi S, Na C, Li B, Zhao Z, Yang T, Yao Y. Rotavirus and Norovirus Infections in Children Under 5 Years Old with Acute Gastroenteritis in Southwestern China, 2018-2020. J Epidemiol Glob Health 2022. [PMID: 35857268 DOI: 10.1007/s44197-022-00050-8] [Reference Citation Analysis]
2 Drakesmith H, Pasricha SR, Cabantchik I, Hershko C, Weiss G, Girelli D, Stoffel N, Muckenthaler MU, Nemeth E, Camaschella C, Klenerman P, Zimmermann MB. Vaccine efficacy and iron deficiency: an intertwined pair? Lancet Haematol 2021;8:e666-9. [PMID: 34450104 DOI: 10.1016/S2352-3026(21)00201-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lockhart A, Mucida D, Parsa R. Immunity to enteric viruses. Immunity 2022;55:800-18. [PMID: 35545029 DOI: 10.1016/j.immuni.2022.04.007] [Reference Citation Analysis]
4 Dolstad HA, Franke MF, Vissieres K, Jerome JG, Ternier R, Ivers LC. Factors associated with diarrheal disease among children aged 1-5 years in a cholera epidemic in rural Haiti. PLoS Negl Trop Dis 2021;15:e0009726. [PMID: 34679083 DOI: 10.1371/journal.pntd.0009726] [Reference Citation Analysis]
5 Philip AA, Patton JT. Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein. Vaccines (Basel) 2021;9:449. [PMID: 34063562 DOI: 10.3390/vaccines9050449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Papa G, Borodavka A, Desselberger U. Viroplasms: Assembly and Functions of Rotavirus Replication Factories. Viruses 2021;13:1349. [PMID: 34372555 DOI: 10.3390/v13071349] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Alamer F, Alamir A, AlJohani S, AlSumih N, Hiji F, Alhammadi M, Almuneef M. Childhood vaccination hesitancy in Saudi Arabia: A time for action. J Infect Public Health 2022;15:94-9. [PMID: 34838473 DOI: 10.1016/j.jiph.2021.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sadiq A, Bostan N, Jadoon Khan, Aziz A. Effect of rotavirus genetic diversity on vaccine impact. Rev Med Virol 2022;32:e2259. [PMID: 34997676 DOI: 10.1002/rmv.2259] [Reference Citation Analysis]
9 Monaco MH, Gross G, Donovan SM. Whey Protein Lipid Concentrate High in Milk Fat Globule Membrane Components Inhibit Porcine and Human Rotavirus in vitro. Front Pediatr 2021;9:731005. [PMID: 34540774 DOI: 10.3389/fped.2021.731005] [Reference Citation Analysis]
10 Cates JE, Amin AB, Tate JE, Lopman B, Parashar U. Do Rotavirus Strains Affect Vaccine Effectiveness? A Systematic Review and Meta-analysis. Pediatr Infect Dis J 2021;40:1135-43. [PMID: 34870393 DOI: 10.1097/INF.0000000000003286] [Reference Citation Analysis]
11 Schäferhoff M, Zimmerman A, Diab MM, Mao W, Chowdhary V, Gill D, Karanja R, Madikizela M, Ogbuoji O, Yamey G. Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries. The Lancet Global Health 2022;10:e1045-52. [DOI: 10.1016/s2214-109x(22)00206-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hallowell BD, Chavers T, Parashar U, Tate JE. Global Estimates of Rotavirus Hospitalizations Among Children Below 5 Years in 2019 and Current and Projected Impacts of Rotavirus Vaccination. J Pediatric Infect Dis Soc 2021:piab114. [PMID: 34904636 DOI: 10.1093/jpids/piab114] [Reference Citation Analysis]
13 Middleton BF, Danchin M, Quinn H, Ralph AP, Pingault N, Jones M, Estcourt M, Snelling T. Retrospective Case-Control Study of 2017 G2P[4] Rotavirus Epidemic in Rural and Remote Australia. Pathogens 2020;9:E790. [PMID: 32993048 DOI: 10.3390/pathogens9100790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang J, Zhang H, Zhang H, Fang H. Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs. Hum Vaccin Immunother 2022;:2090162. [PMID: 35816415 DOI: 10.1080/21645515.2022.2090162] [Reference Citation Analysis]
15 Ni B, Yanis A, Chappell J, Halasa N. Vaccine protection and how we measure it. Transpl Infect Dis 2021;23:e13748. [PMID: 34719856 DOI: 10.1111/tid.13748] [Reference Citation Analysis]
16 Manhas KR, Marshall PA, Wagner CE, Jurutka PW, Mancenido MV, Debray HZ, Blattman JN. Rexinoids Modulate Effector T Cell Expression of Mucosal Homing Markers CCR9 and α4β7 Integrin and Direct Their Migration In Vitro. Front Immunol 2022;13:746484. [PMID: 35154092 DOI: 10.3389/fimmu.2022.746484] [Reference Citation Analysis]
17 Varghese T, Kang G, Steele AD. Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality. Vaccines 2022;10:346. [DOI: 10.3390/vaccines10030346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Shoja Z, Jalilvand S, Latifi T, Roohvand F. Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials. Arch Virol 2022. [PMID: 35292854 DOI: 10.1007/s00705-022-05407-9] [Reference Citation Analysis]
19 Banerjee S, Sarkar R, Mukherjee A, Miyoshi S, Kitahara K, Halder P, Koley H, Chawla-sarkar M. Quercetin, a flavonoid, combats rotavirus infection by deactivating rotavirus-induced pro-survival NF-κB pathway. Front Microbiol 2022;13:951716. [DOI: 10.3389/fmicb.2022.951716] [Reference Citation Analysis]
20 van Dongen JAP, Rouers EDM, Schuurman R, Band C, Watkins SM, van Houten MA, Bont LJ, Norbruis OF, Hemels MAC, van Well GTJ, Vlieger AM, van der Sluijs J, Stas HG, Tramper-Stranders G, Kleinlugtenbeld EA, van Kempen AAMW, Wessels M, van Rossem MC, Dassel CACM, Pajkrt D, Bonten MJM, Bruijning-Verhagen PCJ. Rotavirus Vaccine Safety and Effectiveness in Infants With High-Risk Medical Conditions. Pediatrics 2021;148:e2021051901. [PMID: 34814164 DOI: 10.1542/peds.2021-051901] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Bergman H, Henschke N, Hungerford D, Pitan F, Ndwandwe D, Cunliffe N, Soares-Weiser K. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2021;11:CD008521. [PMID: 34788488 DOI: 10.1002/14651858.CD008521.pub6] [Reference Citation Analysis]
22 Simsek C, Bloemen M, Jansen D, Beller L, Descheemaeker P, Reynders M, Van Ranst M, Matthijnssens J. High Prevalence of Coinfecting Enteropathogens in Suspected Rotavirus Vaccine Breakthrough Cases. J Clin Microbiol 2021;59:e0123621. [PMID: 34586890 DOI: 10.1128/JCM.01236-21] [Reference Citation Analysis]
23 Iaconis G, Jackson B, Childs K, Boyce M, Goodbourn S, Blake N, Iturriza-Gomara M, Seago J. Rotavirus NSP1 Inhibits Type I and Type III Interferon Induction. Viruses 2021;13:589. [PMID: 33807175 DOI: 10.3390/v13040589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kim KG, Kee HY, Park HJ, Chung JK, Kim TS, Kim MJ. The Long-Term Impact of Rotavirus Vaccines in Korea, 2008-2020; Emergence of G8P[8] Strain. Vaccines (Basel) 2021;9:406. [PMID: 33923945 DOI: 10.3390/vaccines9040406] [Reference Citation Analysis]
25 Lin FH, Chou YC, Chen BC, Lu JC, Liu CJ, Hsieh CJ, Yu CP. An Increased Risk of School-Aged Children with Viral Infection among Diarrhea Clusters in Taiwan during 2011-2019. Children (Basel) 2021;8:807. [PMID: 34572239 DOI: 10.3390/children8090807] [Reference Citation Analysis]
26 Chissaque A, Burke RM, Guimarães EL, Manjate F, Nhacolo A, Chilaúle J, Munlela B, Chirinda P, Langa JS, Cossa-moiane I, Anapakala E, Bauhofer AFL, Garrine M, João ED, Sambo J, Gonçalves L, Weldegebriel G, Shaba K, Bello IM, Mwenda JM, Parashar UD, Tate JE, Mandomando I, de Deus N. Effectiveness of Monovalent Rotavirus Vaccine in Mozambique, a Country with a High Burden of Chronic Malnutrition. Vaccines 2022;10:449. [DOI: 10.3390/vaccines10030449] [Reference Citation Analysis]
27 Henschke N, Bergman H, Hungerford D, Cunliffe NA, Grais RF, Kang G, Parashar UD, Wang SA, Neuzil KM. The efficacy and safety of rotavirus vaccines in countries in Africa and Asia with high child mortality. Vaccine 2022:S0264-410X(22)00125-6. [PMID: 35184924 DOI: 10.1016/j.vaccine.2022.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Nazurdinov A, Azizov Z, Mullojonova M, Sadykova U, Mosina L, Singh S, Suleymonova S, Tishkova F, Videbaek D, Cortese MM, Daniels DS, Burke RM. Impact and effectiveness of monovalent rotavirus vaccine in Tajik children. Vaccine 2022:S0264-410X(22)00589-8. [PMID: 35581101 DOI: 10.1016/j.vaccine.2022.05.018] [Reference Citation Analysis]
29 Olsson-Åkefeldt S, Rotzén-Östlund M, Hammas B, Eriksson M, Bennet R. All-cause gastroenteritis hospitalisations of children decreased after the introduction of rotavirus vaccine in Stockholm. Infect Dis (Lond) 2021;:1-8. [PMID: 34569424 DOI: 10.1080/23744235.2021.1982142] [Reference Citation Analysis]
30 Afchangi A, Latifi T, Jalilvand S, Marashi SM, Shoja Z. Combined use of lactic-acid-producing bacteria as probiotics and rotavirus vaccine candidates expressing virus-specific proteins. Arch Virol 2021;166:995-1006. [PMID: 33533975 DOI: 10.1007/s00705-021-04964-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]